The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Post herpetic Neuralgia Treatment Market Research Report 2025
Synopsis
The global market for Post herpetic Neuralgia Treatment was valued at US$ 1714 million in the year 2024 and is projected to reach a revised size of US$ 2247 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Post herpetic Neuralgia Treatment was valued at US$ 1714 million in the year 2024 and is projected to reach a revised size of US$ 2247 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
This report aims to provide a comprehensive presentation of the global market for Post herpetic Neuralgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post herpetic Neuralgia Treatment.
The Post herpetic Neuralgia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post herpetic Neuralgia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post herpetic Neuralgia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Segment by Type
Anticonvulsants
Skin Patch
Other
Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Post herpetic Neuralgia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anticonvulsants
1.2.3 Skin Patch
1.2.4 Other
1.3 Market by Distribution Channel
1.3.1 Global Post herpetic Neuralgia Treatment Market Growth by Distribution Channel: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post herpetic Neuralgia Treatment Market Perspective (2020-2031)
2.2 Global Post herpetic Neuralgia Treatment Growth Trends by Region
2.2.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Post herpetic Neuralgia Treatment Historic Market Size by Region (2020-2025)
2.2.3 Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2026-2031)
2.3 Post herpetic Neuralgia Treatment Market Dynamics
2.3.1 Post herpetic Neuralgia Treatment Industry Trends
2.3.2 Post herpetic Neuralgia Treatment Market Drivers
2.3.3 Post herpetic Neuralgia Treatment Market Challenges
2.3.4 Post herpetic Neuralgia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue
3.1.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue (2020-2025)
3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Post herpetic Neuralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Post herpetic Neuralgia Treatment Revenue
3.4 Global Post herpetic Neuralgia Treatment Market Concentration Ratio
3.4.1 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post herpetic Neuralgia Treatment Revenue in 2024
3.5 Global Key Players of Post herpetic Neuralgia Treatment Head office and Area Served
3.6 Global Key Players of Post herpetic Neuralgia Treatment, Product and Application
3.7 Global Key Players of Post herpetic Neuralgia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Post herpetic Neuralgia Treatment Breakdown Data by Type
4.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Type (2020-2025)
4.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2026-2031)
5 Post herpetic Neuralgia Treatment Breakdown Data by Distribution Channel
5.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Distribution Channel (2020-2025)
5.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2026-2031)
6 North America
6.1 North America Post herpetic Neuralgia Treatment Market Size (2020-2031)
6.2 North America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Post herpetic Neuralgia Treatment Market Size by Country (2020-2025)
6.4 North America Post herpetic Neuralgia Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post herpetic Neuralgia Treatment Market Size (2020-2031)
7.2 Europe Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Post herpetic Neuralgia Treatment Market Size by Country (2020-2025)
7.4 Europe Post herpetic Neuralgia Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size (2020-2031)
8.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post herpetic Neuralgia Treatment Market Size (2020-2031)
9.2 Latin America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2020-2025)
9.4 Latin America Post herpetic Neuralgia Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2020-2031)
10.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Post herpetic Neuralgia Treatment Introduction
11.1.4 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Arbor Pharma
11.2.1 Arbor Pharma Company Details
11.2.2 Arbor Pharma Business Overview
11.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Introduction
11.2.4 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.2.5 Arbor Pharma Recent Development
11.3 Assertio Therapeutics
11.3.1 Assertio Therapeutics Company Details
11.3.2 Assertio Therapeutics Business Overview
11.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Introduction
11.3.4 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.3.5 Assertio Therapeutics Recent Development
11.4 Endo Pharma
11.4.1 Endo Pharma Company Details
11.4.2 Endo Pharma Business Overview
11.4.3 Endo Pharma Post herpetic Neuralgia Treatment Introduction
11.4.4 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.4.5 Endo Pharma Recent Development
11.5 Teikoku Pharma
11.5.1 Teikoku Pharma Company Details
11.5.2 Teikoku Pharma Business Overview
11.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Introduction
11.5.4 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.5.5 Teikoku Pharma Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Post herpetic Neuralgia Treatment Introduction
11.6.4 Teva Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.6.5 Teva Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Post herpetic Neuralgia Treatment Introduction
11.7.4 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.7.5 Mylan Recent Development
11.8 Hengrui Medicine
11.8.1 Hengrui Medicine Company Details
11.8.2 Hengrui Medicine Business Overview
11.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Introduction
11.8.4 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2020-2025)
11.8.5 Hengrui Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Skin Patch
Table 4. Key Players of Other
Table 5. Global Post herpetic Neuralgia Treatment Market Size Growth by Distribution Channel (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Post herpetic Neuralgia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Post herpetic Neuralgia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Post herpetic Neuralgia Treatment Market Share by Region (2020-2025)
Table 9. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Post herpetic Neuralgia Treatment Market Share by Region (2026-2031)
Table 11. Post herpetic Neuralgia Treatment Market Trends
Table 12. Post herpetic Neuralgia Treatment Market Drivers
Table 13. Post herpetic Neuralgia Treatment Market Challenges
Table 14. Post herpetic Neuralgia Treatment Market Restraints
Table 15. Global Post herpetic Neuralgia Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Post herpetic Neuralgia Treatment Market Share by Players (2020-2025)
Table 17. Global Top Post herpetic Neuralgia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2024)
Table 18. Ranking of Global Top Post herpetic Neuralgia Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Post herpetic Neuralgia Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Post herpetic Neuralgia Treatment, Headquarters and Area Served
Table 21. Global Key Players of Post herpetic Neuralgia Treatment, Product and Application
Table 22. Global Key Players of Post herpetic Neuralgia Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Post herpetic Neuralgia Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Post herpetic Neuralgia Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2020-2025) & (US$ Million)
Table 29. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2020-2025)
Table 30. Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2026-2031) & (US$ Million)
Table 31. Global Post herpetic Neuralgia Treatment Revenue Market Share by Distribution Channel (2026-2031)
Table 32. North America Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Post herpetic Neuralgia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Post herpetic Neuralgia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Post herpetic Neuralgia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Post herpetic Neuralgia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Post herpetic Neuralgia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Post herpetic Neuralgia Treatment Product
Table 50. Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Arbor Pharma Company Details
Table 53. Arbor Pharma Business Overview
Table 54. Arbor Pharma Post herpetic Neuralgia Treatment Product
Table 55. Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 56. Arbor Pharma Recent Development
Table 57. Assertio Therapeutics Company Details
Table 58. Assertio Therapeutics Business Overview
Table 59. Assertio Therapeutics Post herpetic Neuralgia Treatment Product
Table 60. Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 61. Assertio Therapeutics Recent Development
Table 62. Endo Pharma Company Details
Table 63. Endo Pharma Business Overview
Table 64. Endo Pharma Post herpetic Neuralgia Treatment Product
Table 65. Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 66. Endo Pharma Recent Development
Table 67. Teikoku Pharma Company Details
Table 68. Teikoku Pharma Business Overview
Table 69. Teikoku Pharma Post herpetic Neuralgia Treatment Product
Table 70. Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 71. Teikoku Pharma Recent Development
Table 72. Teva Company Details
Table 73. Teva Business Overview
Table 74. Teva Post herpetic Neuralgia Treatment Product
Table 75. Teva Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 76. Teva Recent Development
Table 77. Mylan Company Details
Table 78. Mylan Business Overview
Table 79. Mylan Post herpetic Neuralgia Treatment Product
Table 80. Mylan Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Hengrui Medicine Company Details
Table 83. Hengrui Medicine Business Overview
Table 84. Hengrui Medicine Post herpetic Neuralgia Treatment Product
Table 85. Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2020-2025) & (US$ Million)
Table 86. Hengrui Medicine Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Post herpetic Neuralgia Treatment Picture
Figure 2. Global Post herpetic Neuralgia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Post herpetic Neuralgia Treatment Market Share by Type: 2024 VS 2031
Figure 4. Anticonvulsants Features
Figure 5. Skin Patch Features
Figure 6. Other Features
Figure 7. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2020-2031) & (US$ Million)
Figure 8. Global Post herpetic Neuralgia Treatment Market Share by Distribution Channel: 2024 VS 2031
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Post herpetic Neuralgia Treatment Report Years Considered
Figure 13. Global Post herpetic Neuralgia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Post herpetic Neuralgia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Post herpetic Neuralgia Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Post herpetic Neuralgia Treatment Market Share by Players in 2024
Figure 17. Global Top Post herpetic Neuralgia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post herpetic Neuralgia Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Post herpetic Neuralgia Treatment Revenue in 2024
Figure 19. North America Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Post herpetic Neuralgia Treatment Market Share by Country (2020-2031)
Figure 21. United States Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Post herpetic Neuralgia Treatment Market Share by Country (2020-2031)
Figure 25. Germany Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Region (2020-2031)
Figure 33. China Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Post herpetic Neuralgia Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Post herpetic Neuralgia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 49. Arbor Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 50. Assertio Therapeutics Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 51. Endo Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 52. Teikoku Pharma Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 53. Teva Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 54. Mylan Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 55. Hengrui Medicine Revenue Growth Rate in Post herpetic Neuralgia Treatment Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
